1C
GMED icon

1623 Capital’s Globus Medical GMED Stock Holding History

1623 Capital’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,114
Closed -$315K – 63
2021
Q3 		$315K Hold
4,114
– – 0.12% 63
2021
Q2 		$319K Buy
4,114
+1,390
+51% +$98.8K 0.12% 69
2021
Q1 		$168K Buy
+2,724
New +$173K 0.07% 59

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

1623 Capital's GMED Position: Q4 2021 in Review

1623 Capital sold out of Globus Medical (GMED) in Q4 2021, closing a stake of 4,114 shares — an estimated $315K sold.

1623 Capital first reported a position in GMED in Q1 2021 and held it in 3 quarters. The position peaked at $319K in Q2 2021. 373 funds tracked by Wall St. Rank hold GMED as of Q4 2021.

  • 1623 Capital reported no remaining Globus Medical position as of Q4 2021 after selling out during the quarter.
  • 1623 Capital sold 4,114 Globus Medical shares in Q4 2021, an estimated $315K.
  • 1623 Capital first reported a position in Globus Medical in Q1 2021 and held it in 3 quarters.
  • 1623 Capital's Globus Medical position peaked at $319K in Q2 2021.
  • 373 funds tracked by Wall St. Rank held Globus Medical as of Q4 2021.

Based on 1623 Capital's 13F filing for Q4 2021, filed 11 Feb 2022.